Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency... see more

TSX:MBX - Post Discussion

Microbix Biosystems Inc > Bloom Burton drops TP to $0.80
View:
Comment by wizzdumb on Aug 29, 2023 1:46pm
Drop is only due to delay in QAPs sales which was discussed in recent update, Also BB is not including any value for recent Kinlytic agreement at all, which another analyst conservatively estimated as worth $1 per share only for the US and only for catheter clearance.  Regrdless, we're still at thirty and some odd cents so any increase from here, even to a very conservative 80 cents ...more  
Comment by Mbxwatcher on Aug 29, 2023 1:52pm
The Kinlytic sentence is the most important part of this update. They will delve further into Kinlytic's value once the FDA meeting confirms the regulatory pathway. As this has been confirmed with the FDA once (pre-covid) and it is a product that is sorely needed, competitor has a monopoly, we can reasonably hope for positive results. IMO, that is the inflection point for the share price.... ...more  
Comment by wizzdumb on Aug 29, 2023 2:00pm
Agree, decision by Nov 14 at latest, but likely earlier, so in grand scheme of things very soon. In my opinion, it's in the bag. Unfortunately, like everything else with this stock, my expectations of the market actually recognizing the huge potential here is muted. I hope I'm wrong. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities